Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

844 indexed citations

Abstract

loading...

About

This paper, published in 2001, received 844 indexed citations. Written by Gabriele Weitz‐Schmidt, Karl Welzenbach, Volker Brinkmann, Joerg Kallen, Christian Bruns, Sylvain Cottens, Yoshikazu Takada and Ulrich Hommel covering the research area of Immunology and Allergy, Immunology and Radiology, Nuclear Medicine and Imaging. It is primarily cited by scholars working on Surgery (358 citations), Immunology (306 citations) and Molecular Biology (186 citations). Published in Nature Medicine.

In The Last Decade

doi.org/10.1038/89058 →

Countries where authors are citing Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

Specialization
Citations

This map shows the geographic impact of Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site more than expected).

Fields of papers citing Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/89058.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026